Please ensure Javascript is enabled for purposes of website accessibility

Trulieve Cannabis Acquiring Harvest Health & Recreation in $2.1 Billion Deal

By Eric Volkman - May 10, 2021 at 3:50PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The deal creates a new marijuana industry powerhouse.

Trulieve Cannabis (TCNNF 1.23%) is acquiring up-and-coming peer Harvest Health & Recreation (HRVSF) in an all-stock deal, both companies announced Monday.

Harvest stockholders will receive 0.117 of a subordinate voting share of Trulieve for each Harvest share they hold. Based on Friday's closing price for Trulieve, the deal is valued at $2.1 billion. That rate implies a price of $4.79 per share for Harvest, 34% above its closing price Friday.

Two hands holding marijuana leaves.

Image source: Getty Images.

"[O]ur companies share similar customer values with a focus on going deep in core markets," said Trulieve CEO Kim Rivers in their joint press release. "This combination offers us the opportunity to leverage our respective strong foundations and propel us forward with an unparalleled platform for future growth."

While both companies are well-known multistate operators (MSOs), separately their geographic footprints are quite limited. One powerful effect of combining them will be to produce an entity with a dramatically wider presence on both U.S. coasts. The post-merger Trulieve will be active in 11 states, operate 126 dispensaries, and own 3.1 million square feet of cultivation and production facilities. In short, it will be a new cannabis industry powerhouse.

The acquisition has been unanimously approved by the boards of directors of both companies. It will require a two-thirds majority approval by Harvest shareholders to move forward. Given the share price premium they are being offered, it's hard to imagine many will vote against it.

Separately on Monday, Harvest published its first-quarter financial results. Revenue was $88.8 million, up 101% on a year-over-year basis and 27% from the previous quarter. While non-GAAP (adjusted) EBITDA rose almost 200% quarter-over-quarter to $26.9 million, the company's net loss deepened to nearly $23 million from Q1 2020's $15.5 million.

Shares of Harvest climbed nearly 13% on Monday, against the 1% dip of the S&P 500 index. Trulieve's stock closed 5.7% lower.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Trulieve Cannabis Corp. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Trulieve Cannabis Stock Quote
Trulieve Cannabis
$13.15 (1.23%) $0.16
Harvest Health & Recreation Inc. Stock Quote
Harvest Health & Recreation Inc.

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/14/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.